- Home
- LAES vs IMMP Comparison
LAES vs IMMP Comparison
Compare LAES & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- IMMP
- Stock Information
- Founded
- LAES 2022
- IMMP 1987
- Country
- LAES Switzerland
- IMMP Australia
- Employees
- LAES N/A
- IMMP N/A
- Industry
- LAES Semiconductors
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- IMMP Health Care
- Exchange
- LAES Nasdaq
- IMMP Nasdaq
- Market Cap
- LAES 304.2M
- IMMP 251.8M
- IPO Year
- LAES N/A
- IMMP N/A
- Fundamental
- Price
- LAES $3.90
- IMMP $1.57
- Analyst Decision
- LAES Strong Buy
- IMMP Buy
- Analyst Count
- LAES 1
- IMMP 1
- Target Price
- LAES $6.00
- IMMP $7.00
- AVG Volume (30 Days)
- LAES 11.7M
- IMMP 107.8K
- Earning Date
- LAES 07-07-2025
- IMMP 02-27-2025
- Dividend Yield
- LAES N/A
- IMMP N/A
- EPS Growth
- LAES N/A
- IMMP N/A
- EPS
- LAES N/A
- IMMP N/A
- Revenue
- LAES $10,981,000.00
- IMMP $3,019,249.00
- Revenue This Year
- LAES N/A
- IMMP $50.37
- Revenue Next Year
- LAES N/A
- IMMP N/A
- P/E Ratio
- LAES N/A
- IMMP N/A
- Revenue Growth
- LAES N/A
- IMMP 24.11
- 52 Week Low
- LAES $0.29
- IMMP $1.32
- 52 Week High
- LAES $11.00
- IMMP $2.80
- Technical
- Relative Strength Index (RSI)
- LAES 56.54
- IMMP 36.81
- Support Level
- LAES $3.43
- IMMP $1.51
- Resistance Level
- LAES $4.24
- IMMP $1.63
- Average True Range (ATR)
- LAES 0.34
- IMMP 0.08
- MACD
- LAES -0.04
- IMMP -0.03
- Stochastic Oscillator
- LAES 53.62
- IMMP 14.63
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.